A Study Evaluating the Efficacy and Safety of GDC-9545 Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

<http://www.wikidata.org/entity/Q102153630>

clinical trial

rdfs:label	"A Study Evaluating the Efficacy and Safety of GDC-9545 Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer"@en "A Study Evaluating the Efficacy and Safety of GDC-9545 Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer"@nl
schema:description	"تجربة سريرية"@ar "ensayu clínicu"@ast "clinical trial"@en "ensayo clínico"@es "կլինիկական փորձարկում"@hy "治験"@ja "임상시험"@ko "klinisch onderzoek"@nl "клиническое исследование"@ru "клінічне випробування"@uk "thử nghiệm lâm sàng"@vi "临床试验"@zh "临床试验"@zh-hans "臨床試驗"@zh-hant
schema:dateModified	"2026-03-07T10:41:28+00:00"^^xsd:dateTime
schema:version	2470131436
wikibase:identifiers	1
wikibase:sitelinks	0
wikibase:statements	18
p:P1132	wd:statement/Q102153630-18CCAFB5-FD9F-4635-906C-FBA61DAE27F9
p:P1476	wd:statement/Q102153630-EEFF0474-240C-46B7-BE90-B61F05ADAC91
p:P17	wd:statement/Q102153630-04388892-AF56-41FC-B299-B6CCCAFB2F37
p:P2899	wd:statement/Q102153630-BD0887C4-6A29-407E-B07B-BDA488B1C0A6
p:P3098	wd:statement/Q102153630-E1C8CDC3-CB97-4B2F-8288-9779926CB9CF
p:P31	wd:statement/Q102153630-D580665F-286E-42E0-8DFD-AAF6827A7D62
p:P4844	wd:statement/Q102153630-35CAD1D3-EB77-48BC-8C40-73187F328F1B
	wd:statement/Q102153630-CA657ABC-09F3-4387-A2E0-4F80132A06C0
p:P580	wd:statement/Q102153630-C55611D9-038C-4C7A-9A7C-2AB7FDDECD5B
p:P582	wd:statement/Q102153630-F0468593-8632-4054-93AA-B12DE7C9F664
p:P6099	wd:statement/Q102153630-4B3761F5-F8E7-4102-ADF6-0E4D78EC2E93
p:P6153	wd:statement/Q102153630-3E4D45AD-A204-42D8-8795-7A460023F442
	wd:statement/Q102153630-95D545BF-A2FF-462E-A097-8A888A015936
	wd:statement/Q102153630-B1E77D04-5AA3-488D-80B7-E8638D27BBD3
	wd:statement/Q102153630-F23B4867-A96C-427B-958D-C49276F7C3EF
p:P8005	wd:statement/Q102153630-E104BE4E-2F10-46D4-B727-E3834B5F9467
p:P8363	wd:statement/Q102153630-44A0D528-49F1-4BF6-B4BC-2C9558ADBB41
p:P859	wd:statement/Q102153630-649C48C9-A855-415E-A65E-540B0846D728
wdt:P1132	300.0^^xsd:decimal
wdt:P1476	"A Phase II, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Compared With Physician's Choice of Endocrine Monotherapy in Patients With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer"@en
wdt:P17	Tingëb nga manga Estado
wdt:P2899	18.0^^xsd:decimal
wdt:P3098	"NCT04576455"
wdt:P31	Կլինիկական փորձարկումներ
wdt:P4844	aromataseremmers
	Fulvestranto
wdt:P580	"2020-11-30T00:00:00+00:00"^^xsd:dateTime
wdt:P582	"2022-03-15T00:00:00+00:00"^^xsd:dateTime
wdt:P6099	fazo 2 de klinika studo
wdt:P6153	서울대학교병원
	ソウル峨山病院
	Jonsze Egyetem
	三星醫療院
wdt:P8005	招募中
wdt:P8363	estudo intervencional
wdt:P859	Hoffmann-La Roche